CME
February 14, 2024 - AI Summary
Overvalued by 11.2% based on the discounted cash flow analysis.
Market cap | $75.48 Billion |
---|---|
Enterprise Value | $75.88 Billion |
Dividend Yield | $9.4313 (4.5%) |
Earnings per Share | $8.86 |
Beta | 0.25 |
Outstanding Shares | 360,025,217 |
Avg 30 Day Volume | 1,634,345 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.69 |
---|---|
PEG | 85.64 |
Price to Sales | 14.17 |
Price to Book Ratio | 2.87 |
Enterprise Value to Revenue | 13.6 |
Enterprise Value to EBIT | 20.33 |
Enterprise Value to Net Income | 23 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.13 |
No data
No data